Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More Analysis and Commentary STEVEN GROSSMAN 8/7/20 Analysis and Commentary STEVEN GROSSMAN 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/16/21 Advocacy at a Glance STEVEN GROSSMAN 4/16/21 The Alliance is beginning Hill Day meetings. Acting FDA Commissioner Woodcock responded to a wide range of questions during her meeting with the Alliance. Read More
Analysis and Commentary STEVEN GROSSMAN 10/24/20 Analysis and Commentary STEVEN GROSSMAN 10/24/20 FY 21, FY 22 Appropriations and CDER Priorities Read More
Analysis and Commentary STEVEN GROSSMAN 10/9/20 Analysis and Commentary STEVEN GROSSMAN 10/9/20 Webinar on Budget, Workload, and Other Priorities for CDER Read More
Analysis and Commentary STEVEN GROSSMAN 8/7/20 Analysis and Commentary STEVEN GROSSMAN 8/7/20 CDER Priorities: During the Pandemic and for 2021 Read More
Advocacy at a Glance STEVEN GROSSMAN 8/7/20 Advocacy at a Glance STEVEN GROSSMAN 8/7/20 What We Learned: A Meeting with CDER Deputy Center Director for Operations Dr. Patrizia Cavazzoni Read More
Analysis and Commentary STEVEN GROSSMAN 9/28/18 Analysis and Commentary STEVEN GROSSMAN 9/28/18 Janet Woodcock on CDER's Needs and Opportunities Read More
Advocacy at a Glance STEVEN GROSSMAN 9/28/18 Advocacy at a Glance STEVEN GROSSMAN 9/28/18 FDA Appropriations in Limbo and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Advocacy at a Glance STEVEN GROSSMAN 8/5/18 Senate Passes FY 19 Ag/FDA Funding as Part of 4-bill Mini-bus Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More
Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Advocacy at a Glance STEVEN GROSSMAN 1/23/16 Federal Deficit Certain to Grow Over Next 10 Years and more Read More
